india glp 1 🚀 The Generic GLP-1 Revolution: India's $1B Opportunity March 20, 2026 marked a watershed moment—semaglutide's patent expiry unleashed 50+ generic launches in India. Within days, prices crashed 70-90%: ₹1,290/vial (Natco) vs ₹4,200+ ( Indian startup Good Bug unveils

& Peng, L

it also offers potential benefits for brain health

J Biol Chem 229:189197 Rotruck JT, Pope AL, Ganther HE et al (1973) Selenium: biochemical role as a component of glutathione peroxidase

An application for this additional indication for use is pending with the FDA, and a decision is expected early next year

It may be that a discussion is needed to explore other potential causes for the symptoms or to re-evaluate the patients current treatment plan, but an early injection might not be the standard solution

The weight-adjusted approach matters more for peptides with narrow therapeutic windows or those where body composition significantly affects distribution